Remove Drug Pricing Remove Pharmaceutical Companies Remove Specialty Pharmacies
article thumbnail

Conference Connect: Determining the Future of Specialty Pharmacy

Pharmaceutical Commerce

Asembia’s AXS25 Summit—held annually at both the Wynn and Encore in Las Vegas, NV—brings together thousands of pharmaceutical industry executives in hopes of continuing the conversation surrounding specialty pharmacy.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

This pathway’s expanded use and shifting Centers for Medicare & Medicaid Services (CMS) policies are reshaping reimbursement practices and therapeutic equivalence standards for 505(b)(2) drugs. Based on this ruling, 505(b)(2) drugs that are not therapeutically interchangeable should be considered sole-source drugs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Informa Connect’s Compliance Congress for Specialty Products

Drug Channels

Join the compliance community for dynamic discussions on the top risk areas for specialty pharmaceutical companies, including speaker programs, patient support programs, charitable donations, specialty pharmacy relationships, patient advocacy group interactions, mergers and acquisitions, medical affairs activities, drug pricing, transparency and more! (..)

article thumbnail

5 questions on Sarepta, the FDA and a Duchenne gene therapy crisis

BioPharma Dive

Editors picks George Frey/Reuters Deep Dive A decade of cancer immunotherapy: Keytruda, Opdivo and the drugs that changed oncology Over the past 10 years, PD1-blocking medicines have transformed cancer care. Company Announcements View all | Post a press release Cycle Pharmaceuticals Selects LeMed Specialty Pharmacy as Exclusive U.S.